Your browser doesn't support javascript.
loading
Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.
Sommerer, Claudia; Duerr, Michael; Witzke, Oliver; Lehner, Frank; Arns, Wolfgang; Kliem, Volker; Ackermann, Daniel; Guba, Markus; Jacobi, Johannes; Hauser, Ingeborg A; Stahl, Rolf; Reinke, Petra; Rath, Thomas; Veit, Justyna; Mehrabi, Arianeb; Porstner, Martina; Budde, Klemens.
Afiliación
  • Sommerer C; Department of Nephrology, University of Heidelberg, Heidelberg, Germany.
  • Duerr M; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Witzke O; Department of Infectious Diseases & Department of Nephrology, University Duisburg-Essen, Essen, Germany.
  • Lehner F; Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany.
  • Arns W; Department of Nephrology and Transplantation, Cologne Merheim Medical Center, Cologne, Germany.
  • Kliem V; Department of Internal Medicine and Nephrology, Kidney Transplant Center, Nephrological Center of Lower Saxony, Klinikum, Hann Münden, Germany.
  • Ackermann D; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Guba M; Department of General-, Visceral- and Transplantation Surgery, Munich University Hospital, Munich, Germany.
  • Jacobi J; Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen, Germany.
  • Hauser IA; Department of Nephrology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Stahl R; Department of Internal Medicine III Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
  • Reinke P; Department of Nephrology and Intensive Care, Charité Campus Virchow, Charite-Universitätsmedizin Berlin, Berlin, Germany.
  • Rath T; Department of Nephrology and Transplantation Medicine, Westpfalz-Klinikum, Kaiserslautern, Germany.
  • Veit J; Novartis Pharma GmbH, Nuernberg, Germany.
  • Mehrabi A; Department of General, Visceral and Transplantation Surgery, INF 110, University of Heidelberg, Heidelberg, Germany.
  • Porstner M; Novartis Pharma GmbH, Nuernberg, Germany.
  • Budde K; Department of Nephrology and Internal Intensive Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Am J Transplant ; 18(12): 2965-2976, 2018 12.
Article en En | MEDLINE | ID: mdl-29722128
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Ciclosporina / Everolimus / Rechazo de Injerto / Supervivencia de Injerto / Inmunosupresores / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Ciclosporina / Everolimus / Rechazo de Injerto / Supervivencia de Injerto / Inmunosupresores / Fallo Renal Crónico Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos